Combined detection of urinary-related protein and fecal calprotectin for early warning of IgA vasculitis with nephritis in children

Lin-Yan YE, Ren-Bin ZHOU, Min XIE, Hai-Rong ZHOU, Xin-Zhou CHEN

Chinese Journal of Contemporary Pediatrics ›› 2026, Vol. 28 ›› Issue (9) : 1093-1098.

PDF(677 KB)
PDF(677 KB)
Chinese Journal of Contemporary Pediatrics ›› 2026, Vol. 28 ›› Issue (9) : 1093-1098. DOI: 10.7499/j.issn.1008-8830.2512060
CLINICAL RESEARCH

Combined detection of urinary-related protein and fecal calprotectin for early warning of IgA vasculitis with nephritis in children

Author information +
History +

Abstract

Objective To evaluate the early warning value of combined detection of urinary neutrophil gelatinase-associated lipocalin (NGAL), urinary microalbumin and fecal calprotectin for IgA vasculitis with nephritis (IgAVN). Methods A total of 90 children with IgAV and 50 healthy children undergoing physical examination at Yichun People's Hospital from January 2024 to December 2025 were enrolled. Based on urinalysis at admission and at 3-month follow-up, IgAV cases were classified into a simple IgAV group (n=48) and an IgAVN group (n=42; abnormal urinalysis). The IgAVN group was further divided into a mild renal injury subgroup (n=25) and a moderate-to-severe renal injury subgroup (n=17). Pearson correlation analysis, multivariable logistic regression and receiver operating characteristic (ROC) curve analysis were used to assess the diagnostic and early warning value of each marker. Results Levels of urinary NGAL, urinary microalbumin and fecal calprotectin in the IgAVN group were significantly higher than those in the simple IgAV group and the control group (P<0.05). Children with moderate-to-severe renal injury had higher levels of all three markers than those with mild renal injury (P<0.05). Correlation analysis showed that all three markers were significantly positively correlated with the severity of renal injury (P<0.05). ROC analysis indicated that combined detection of the three markers provided significantly better early warning performance than any single marker (P<0.05). Conclusions Combined detection of urinary NGAL, urinary microalbumin and fecal calprotectin improves early warning for IgAVN in children, providing a reliable laboratory basis for early clinical intervention and better prognosis.

Key words

IgA vasculitis with nephritis / Neutrophil gelatinase-associated lipocalin / Urinary microalbumin / Fecal calprotectin / Warning / Child

Cite this article

Download Citations
Lin-Yan YE , Ren-Bin ZHOU , Min XIE , et al . Combined detection of urinary-related protein and fecal calprotectin for early warning of IgA vasculitis with nephritis in children[J]. Chinese Journal of Contemporary Pediatrics. 2026, 28(9): 1093-1098 https://doi.org/10.7499/j.issn.1008-8830.2512060

References

[1]
Castañeda S, Quiroga-Colina P, Floranes P, et al. IgA vasculitis (Henoch-Schönlein purpura): an update on treatment[J]. J Clin Med, 2024, 13(21): 6621. PMCID: PMC11546386. DOI: 10.3390/jcm13216621 .
[2]
Min S, Chen X, Wang D, et al. Risk factors for renal involvement in childhood Henoch-Schönlein purpura (IgA vasculitis)[J]. J Coll Physicians Surg Pak, 2024, 34(10): 1258-1261. DOI: 10.29271/jcpsp.2024.10.1258 .
[3]
Kim WK, Kim CJ, Yang EM. Risk factors for renal involvement in Henoch-Schönlein purpura[J]. J Pediatr (Rio J), 2021, 97(6): 646-650. PMCID: PMC9432244. DOI: 10.1016/j.jped.2021.01.008 .
[4]
Bista S, Adhikari Y, Karmacharya S, et al. Henoch-Schönlein purpura with antecedent allergic diseases in a 4-year-old child: a case report[J]. Ann Med Surg (Lond), 2023, 85(6): 3066-3069. PMCID: PMC10289484. DOI: 10.1097/MS9.0000000000000782 .
[5]
Xiong Y, Cuevas S, Xu G, et al. The efficacy of rituximab in the treatment of IgA vasculitis nephritis[J]. Clin Exp Med, 2024, 24(1): 213. PMCID: PMC11383840. DOI: 10.1007/s10238-024-01461-6 .
[6]
朱雨婷, 董晨, 关凤军. Gd-IgA1和NGAL检测在儿童紫癜性肾炎早期诊断中的应用价值[J]. 医学研究杂志, 2022, 51(5): 118-122. DOI: 10.11969/j.issn.1673-548X.2022.05.026 .
[7]
赵扬扬, 陈欢欢, 王昕, 等. 补体C3、C4、CysC及尿微量白蛋白检测对过敏性紫癜患儿早期肾损伤的评估价值[J]. 分子诊断与治疗杂志, 2025, 17(5): 935-938, 947. DOI: 10.3969/j.issn.1674-6929.2025.05.037 .
[8]
王叶萍, 吴绿仙, 应玲静, 等. 粪钙卫蛋白和促胃液素在腹型过敏性紫癜患儿早期诊断中的应用价值[J]. 浙江中西医结合杂志, 2025, 35(2): 142-145. DOI: 10.3969/j.issn.1005-4561.2025.02.010 .
[9]
中华医学会儿科学分会免疫学组, 中华儿科杂志编辑委员会, 中国儿童风湿免疫病联盟. 中国儿童IgA血管炎诊断与治疗指南(2023)[J]. 中华儿科杂志, 2023, 61(12): 1067-1076. DOI: 10.3760/cma.j.cn112140-20230731-00055 .
[10]
刘许蒙, 雷群娟, 梁冬梅, 等. 人工智能辅助识别IgA肾病和过敏性紫癜性肾炎的肾小球病理特征[J]. 医学研究与战创伤救治, 2024, 37(9): 926-933. DOI: 10.16571/j.cnki.2097-2768.2024.09.006 .
[11]
王紫薇, 李闵, 高慧, 等. 链球菌感染与过敏性紫癜肾炎患儿肾损害的相关性[J]. 北京大学学报(医学版), 2025, 57(2): 284-290. PMCID: PMC11992448. DOI: 10.19723/j.issn.1671-167X.2025.02.010 .
[12]
贾卉娟, 田丽, 李胜元. 过敏性紫癜肾炎患儿血清YKL-40、sCD163水平及其对预后的预测价值[J]. 国际检验医学杂志, 2025, 46(9): 1092-1096, 1103. DOI: 10.3969/j.issn.1673-4130.2025.09.014 .
[13]
徐建涛, 孙清. 加减银翘散结合西药对预防儿童过敏性紫癜早期肾损害及尿NGAL的影响[J]. 世界最新医学信息文摘(连续型电子期刊), 2020, 20(78): 203-204. DOI: 10.3969/j.issn.1671-3141.2020.78.085 .
[14]
Gkiourtzis N, Stoimeni A, Michou P, et al. The NGAL as a prognostic biomarker of kidney injury in children and adolescents with type 1 diabetes mellitus: a systematic review and meta-analysis[J]. J Diabetes Complications, 2025, 39(5): 109002. DOI: 10.1016/j.jdiacomp.2025.109002 .
[15]
Balkrishna A, Gohel V, Pathak N, et al. Renogrit selectively protects against cisplatin-induced injury in human renal tubular cells and in Caenorhabditis elegans by harmonizing apoptosis and mitophagy[J]. Sci Rep, 2024, 14(1): 19443. PMCID: PMC11339073. DOI: 10.1038/s41598-024-69797-3 .
[16]
刘霞, 曹静, 沈红. 肾主动脉血流动力学指标与尿微量白蛋白在过敏性紫癜患儿早期肾损害中的应用价值[J]. 广西医学, 2024, 46(12): 1858-1863. DOI: 10.11675/j.issn.0253-4304.2024.12.08 .
[17]
Huang H, Jiang XF, Yang XY, et al. Urinary microalbumin predicts early neurological deterioration in acute ischemic stroke: a study based on etiological classification[J]. J Stroke Cerebrovasc Dis, 2024, 33(12): 108044. DOI: 10.1016/j.jstrokecerebrovasdis.2024.108044 .
[18]
赵莺, 徐锦. 粪便钙卫蛋白在儿童炎症性肠病中的临床意义[J]. 检验医学, 2022, 37(5): 429-432. DOI: 10.3969/j.issn.1673-8640.2022.05.006 .
[19]
Kato R, Oguri M, Tsubata S, et al. Clinical significance of fecal calprotectin for evaluating mucosal inflammation with IgA vasculitis[J]. JMA J, 2022, 5(2): 277-279. PMCID: PMC9090550. DOI: 10.31662/jmaj.2021-0173 .
[20]
Zhang ZH, Wang W, Zhang XH, et al. Fecal calprotectin in children with cow's milk protein allergy: a systematic review and meta-analysis[J]. Int Arch Allergy Immunol, 2022, 183(11): 1189-1197. DOI: 10.1159/000525961 .

Footnotes

作者均声明无利益冲突。

PDF(677 KB)

Accesses

Citation

Detail

Sections
Recommended

/